Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia

• by Shota Kato, Aiko Sato-Otsubo, Wataru Nakamura, Masahiro Sugawa, Ai Okada, Kenichi Chiba, Nao Takasugi, Tomoya Irikura, Moe Hidaka, Masahiro Sekiguchi, Kentaro Watanabe, Yuichi Shiraishi, Motohiro Kato

• August 28, 2024

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

• by

• December 17, 2025

• 4 min

Delays in Diagnosis of Hematological Cancers in Children: An Analysis of Symptom Recognition to Diagnosis Timeline and Contributing Factors at a Tertiary Hospital in Uganda

• by Joan Nakabiri, Brian Agaba, Ronald Naitala, Betty Najjuuko, Catherine Asiimwe, Hellen Alamo, Brian Mafabi, Marilyn Hockenberry, John M. Ssenkusu, Victoria Nankabirwa

• November 12, 2025

Which Patients Seek Second Opinions?

A Keck Medicine of USC hematologist-oncologist shares his insights on second opinions.

• by

• February 26, 2025

• 6 min